AimTo identify differences in brain morphology between dependent and non‐dependent male anabolic–androgenic steroid (AAS) users.DesignThis study used cross‐sectional data from a longitudinal study on male weightlifters.ParticipantsOslo University Hospital, Norway.SettingEighty‐one AAS users were divided into two groups; AAS‐dependent (n = 43) and AAS‐non‐dependent (n = 38).MeasurementsNeuroanatomical volumes and cerebral cortical thickness were estimated based on magnetic resonance imaging (MRI) using FreeSurfer. Background and health information were obtained using a semi‐structured interview. AAS‐dependence was evaluated in a standardized clinical interview using a version of the Structured Clinical Interview for DSM‐IV, adapted to apply to AAS‐dependence.FindingsCompared with non‐dependent users, dependent users had significantly thinner cortex in three clusters of the right hemisphere and in five clusters of the left hemisphere, including frontal, temporal, parietal and occipital regions. Profound differences were seen in frontal regions (left pars orbitalis, cluster‐wise P < 0.001, right superior frontal, cluster‐wise P < 0.001), as has been observed in other dependencies. Group differences were also seen when excluding participants with previous or current non‐AAS drug abuse (left pre‐central, cluster‐wise P < 0.001, left pars orbitalis, cluster‐wise P = 0.010).ConclusionMale dependent anabolic–androgenic steroid users appear to have thinner cortex in widespread regions, specifically in pre‐frontal areas involved in inhibitory control and emotional regulation, compared with non‐dependent anabolic–androgenic steroid users.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.